PEMBRO-K : Evaluation of Pembrolizumab Therapeutic Pharmacological Monitoring Benefit in NSCLC
NCT06195527
·
clinicaltrials.gov ↗
RECRUITING
Status
75
Enrollment
OTHER_GOV
Sponsor class
Conditions
Non Small Cell Lung Cancer
Sponsor
University Hospital, Angers